Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 9/20 | 0.50 |
| ▸ | HTT | P42858 | 5/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.50 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9428188 | 0.85 | FTO (0.56) | FTOHTTHPGDTDP1MEN1 | |
| SCHEMBL5149281 | 0.84 | FTO (0.55) | FTOHTTHPGDTDP1MEN1 | |
| SCHEMBL9427469 | 0.84 | HPGD (0.56) | FTOHTTHPGDTDP1MEN1 | |
| SCHEMBL1254421 | 0.84 | FTO (0.64) | FTOHTTHPGDTDP1MEN1 | |
| SCHEMBL7521638 | 0.82 | FTO (0.53) | FTOHTTHPGDTDP1MEN1 | |
| SCHEMBL183875 | 0.81 | FTO (0.52) | FTOHTTHPGDTDP1MEN1 | |
| SCHEMBL291009 | 0.81 | FTO (0.66) | FTOHTTHPGDTDP1MEN1 | |
| SCHEMBL7646663 | 0.81 | FTO (0.52) | FTOHTTHPGDTDP1MEN1 | |
| SCHEMBL11310755 | 0.81 | FTO (0.52) | FTOHTTHPGDTDP1MEN1 | |
| SCHEMBL1978381 | 0.81 | FTO (0.52) | FTOHTTHPGDTDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050266065-A1 | Hydrated lamellar phases or liposomes which contain a fatty monoamine or a cationic polymer which promotes intracellular penetration, and a cosmetic or pharmaceutical composition containing same, as well as a method of screening such a substance | COLETICA (FR) | 2005-12-01 | — | — | US | claimed |
| US-9655822-B2 | Hydrated lamellar phases or liposomes which contain a fatty monoamine or a cationic polymer which promotes intracellular penetration, and a cosmetic or pharmaceutical composition containing same, as well as a method of screening such a substance | BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) | 2017-05-23 | — | — | US | disclosed |
| EP-2764119-A2 | METHOD FOR DETECTING REPLICATION OR COLONIZATION OF A BIOLOGICAL THERAPEUTIC | Genelux Corporation (US) | 2014-08-13 | — | — | EP | disclosed |
| WO-2013052915-A2 | METHOD FOR DETECTING REPLICATION OR COLONIZATION OF A BIOLOGICAL THERAPEUTIC | GENELUX CORPORATION (US) | 2013-04-11 | — | — | WO | disclosed |
| US-20050266065-A1 | Hydrated lamellar phases or liposomes which contain a fatty monoamine or a cationic polymer which promotes intracellular penetration, and a cosmetic or pharmaceutical composition containing same, as well as a method of screening such a substance | COLETICA (FR) | 2005-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050266065-A1 | Hydrated lamellar phases or liposomes which contain a fatty monoamine or a cationic polymer which promotes intracellular penetration, and a cosmetic or pharmaceutical composition containing same, as well as a method of screening such a substance | SLC18A1, SLC18A2, SGMS2 | FTO 1802/4885HTT 418/4885HPGD 1924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.